| Study Enrollment (44 patients) | ||
| Cohort 1 (50 mg/m2), n = 3 | Cohort 5 (219 mg/m2), n = 10 | |
| Cohort 2 (75 mg/m2), n = 3 | Cohort 6 (285 mg/m2), n = 3 | |
| Cohort 3 (112.5 mg/m2), n = 4 | Cohort 7 (427 mg/m2), n = 8 | |
| Cohort 4 (146 mg/m2), n = 4 | Cohort 8 (555 mg/m2), n = 9 | |
| Characteristics | N | N (%) |
| Age (years old) | 44 |
|
| Median |
| 57.7 |
| 18 to 64 |
| 31 (70.5) |
| 65+ |
| 13 (29.5) |
| Sex | 44 |
|
| Male |
| 23 (52.3) |
| Female |
| 21 (47.7) |
| Ethnic Origin | 44 |
|
| White |
| 43 (97.7) |
| Hispanic or Latino |
| 1 (2.3) |
| Performance Status | 44 |
|
| 0 |
| 10 (22.7) |
| 1 |
| 29 (65.9) |
| 2 |
| 5 (11.4) |